PEA15

Astrocytic phosphoprotein PEA-15 is a protein that in humans is encoded by the PEA15 gene.[5][6]

PEA15
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesPEA15, HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, phosphoprotein enriched in astrocytes 15, PED-PED/proliferation and apoptosis adaptor protein 15
External IDsOMIM: 603434 MGI: 104799 HomoloGene: 7884 GeneCards: PEA15
Orthologs
SpeciesHumanMouse
Entrez

8682

18611

Ensembl

ENSG00000162734

ENSMUSG00000013698

UniProt

Q15121

Q62048

RefSeq (mRNA)

NM_001297576
NM_001297577
NM_001297578
NM_003768

NM_011063
NM_001329869
NM_001329871
NM_008556

RefSeq (protein)

NP_001316798
NP_001316800
NP_035193

Location (UCSC)Chr 1: 160.21 – 160.22 MbChr 1: 172.02 – 172.03 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

PEA15 is a death effector domain (DED)-containing protein predominantly expressed in the central nervous system, particularly in astrocytes.[6]

PEA-15 promotes autophagy in glioma cells in a JNK-dependent manner.[7]

Interactions

PEA15 has been shown to interact with:

References

  1. GRCh38: Ensembl release 89: ENSG00000162734 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000013698 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Hwang S, Kuo WL, Cochran JF, Guzman RC, Tsukamoto T, Bandyopadhyay G, Myambo K, Collins CC (September 1997). "Assignment of HMAT1, the human homolog of the murine mammary transforming gene (MAT1) associated with tumorigenesis, to 1q21.1, a region frequently gained in human breast cancers". Genomics. 42 (3): 540–2. doi:10.1006/geno.1997.4768. PMID 9205133.
  6. "Entrez Gene: PEA15 phosphoprotein enriched in astrocytes 15".
  7. Böck BC, Tagscherer KE, Fassl A, Krämer A, Oehme I, Zentgraf HW, Keith M, Roth W (July 2010). "The PEA-15 protein regulates autophagy via activation of JNK". J. Biol. Chem. 285 (28): 21644–54. doi:10.1074/jbc.M109.096628. PMC 2898427. PMID 20452983.
  8. Kitsberg D, Formstecher E, Fauquet M, Kubes M, Cordier J, Canton B, Pan G, Rolli M, Glowinski J, Chneiweiss H (October 1999). "Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis". J. Neurosci. 19 (19): 8244–51. doi:10.1523/JNEUROSCI.19-19-08244.1999. PMC 6783010. PMID 10493725.
  9. Condorelli G, Vigliotta G, Cafieri A, Trencia A, Andalò P, Oriente F, Miele C, Caruso M, Formisano P, Beguinot F (August 1999). "PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis". Oncogene. 18 (31): 4409–15. doi:10.1038/sj.onc.1202831. PMID 10442631. S2CID 20510429.
  10. Formstecher E, Ramos JW, Fauquet M, Calderwood DA, Hsieh JC, Canton B, Nguyen XT, Barnier JV, Camonis J, Ginsberg MH, Chneiweiss H (August 2001). "PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase". Dev. Cell. 1 (2): 239–50. doi:10.1016/s1534-5807(01)00035-1. PMID 11702783.
  11. Zhang Y, Redina O, Altshuller YM, Yamazaki M, Ramos J, Chneiweiss H, Kanaho Y, Frohman MA (November 2000). "Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them". J. Biol. Chem. 275 (45): 35224–32. doi:10.1074/jbc.M003329200. PMID 10926929.
  12. Vaidyanathan H, Ramos JW (August 2003). "RSK2 activity is regulated by its interaction with PEA-15". J. Biol. Chem. 278 (34): 32367–72. doi:10.1074/jbc.M303988200. PMID 12796492.

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.